Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.

D. Iturbe Fernández (Santander, Spain), A. De Pablo Gafas (Madrid, Spain), K. Escobar Ramírez (Santander, Spain), . Ruiz Sáinz (Santander, Spain), V. Pérez González (Madrid, Spain), V. Mora Cuesta (Santander, Spain), S. Fernández Rozas (Santander, Spain), R. Alonso Moralejo (Madrid, Spain), J. Cifrián Martínez (Santander, Spain)

Source: International Congress 2019 – Lung transplantation: from bench to bedside
Session: Lung transplantation: from bench to bedside
Session type: Thematic Poster
Number: 1103

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Iturbe Fernández (Santander, Spain), A. De Pablo Gafas (Madrid, Spain), K. Escobar Ramírez (Santander, Spain), . Ruiz Sáinz (Santander, Spain), V. Pérez González (Madrid, Spain), V. Mora Cuesta (Santander, Spain), S. Fernández Rozas (Santander, Spain), R. Alonso Moralejo (Madrid, Spain), J. Cifrián Martínez (Santander, Spain). Everolimus as a treatment of Chronic Lung Alograft Rejection (CLAD) in lung transplantation.. 1103

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Lung transplantation
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Lung transplantation
Source: Eur Respir Monogr 2014; 66: 60-70
Year: 2014


Lung transplantation
Source: ERS course 2015
Year: 2015

Lung transplantation
Source: ERS Course 2016
Year: 2016




Lung transplantation
Source: School Course 2014 - Interstitial lung diseases
Year: 2014


Lung transplantation
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Lung transplantation
Source: Breathe, 14 (4) 276; 10.1183/20734735.027618
Year: 2018



Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Lung transplantation: beyond palliation
Source: Eur Respir J 2003; 22: 721-722
Year: 2003

The effect of everolimus on lung function and renal status in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Inflammatory response following DCD and DBD lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Lung transplantation
Source: Procedure Video 2011
Year: 2011